Recent studies have reported that the expression of KLF4 correlates with poor survival and response to treatment in pediatric patients with Burkitt’s lymphoma (14), and it has also been described that KLF4 regulates the cell cycle in hematologic malignancies (34), and is expressed in leukemia and lymphoma cell lines. Here, KLF4 is linked to leukemia.